TABLE-Hisamitsu <4530.T>-6mth group results

Sept 30 (Reuters) -

HISAMITSU PHARMACEUTICAL CO INC

CONSOLIDATED FINANCIAL HIGHLIGHTS

(in billions of yen unless specified)

6 months ended 6 months ended Full year to Full year ended

Aug 31, 2009 Aug 31, 2008 Feb 28, 2010 Feb 28, 2009

LATEST YEAR-AGO COMPANY YEAR-AGO

H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 64.80 63.58 128.60

(+5.3 pct) (+3.2%)
Operating 15.59 16.95 32.80

(+20.0 pct) (+0.8%)
Recurring 16.08 17.58 33.10

(+20.3 pct) (+1.9%)
Net 9.57 11.22 19.80

(+26.6 pct) (+3.6%)
EPS Y109.15 Y126.51 Y225.84
Annual div Y68.00 Y63.00
-Q2 div Y34.00 Y31.50
-Q4 div Y31.50 Y34.00

NOTE - Hisamitsu Pharmaceutical Co Inc is a major maker of anti-inflammatory
analgesic agents.

For latest earnings estimates made by Toyo Keizai, please
double click on 4530.TK1.